Literature DB >> 33392514

PRPS-ST: A protocol-agnostic self-training method for gene expression-based classification of blood cancers.

Aixiang Jiang1,2,3, Laura K Hilton2,4, Jeffrey Tang3, Christopher K Rushton3, Bruno M Grande2,3, David W Scott2,5, Ryan D Morin6,4.   

Abstract

Gene expression classifiers are gaining increasing popularity for stratifying tumors into subgroups with distinct biological features. A fundamental limitation shared by current classifiers is the requirement for comparable training and testing data sets. Here, we describe a self-training implementation of our probability ratio-based classification prediction score method (PRPS-ST), which facilitates the porting of existing classification models to other gene expression data sets. In comparison to gold standards, we demonstrate favorable performance of PRPS-ST in gene expression-based classification of DLBCL and B-ALL using a diverse variety of gene expression data types and pre-processing methods, including in classifications with a high degree of class imbalance. Tumors classified by our method were significantly enriched for prototypical genetic features of their respective subgroups. Interestingly, this included cases that were unclassifiable by established methods, implying the potential enhanced sensitivity of PRPS-ST.

Entities:  

Keywords:  B-ALL; binary classifier; hematologic; machine learning; molecular subgroup

Mesh:

Year:  2020        PMID: 33392514      PMCID: PMC7774870          DOI: 10.1158/2643-3230.BCD-20-0076

Source DB:  PubMed          Journal:  Blood Cancer Discov        ISSN: 2643-3230


  37 in total

1.  Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning.

Authors:  Margaret A Shipp; Ken N Ross; Pablo Tamayo; Andrew P Weng; Jeffery L Kutok; Ricardo C T Aguiar; Michelle Gaasenbeek; Michael Angelo; Michael Reich; Geraldine S Pinkus; Tane S Ray; Margaret A Koval; Kim W Last; Andrew Norton; T Andrew Lister; Jill Mesirov; Donna S Neuberg; Eric S Lander; Jon C Aster; Todd R Golub
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

2.  Strelka2: fast and accurate calling of germline and somatic variants.

Authors:  Sangtae Kim; Konrad Scheffler; Aaron L Halpern; Mitchell A Bekritsky; Eunho Noh; Morten Källberg; Xiaoyu Chen; Yeonbin Kim; Doruk Beyter; Peter Krusche; Christopher T Saunders
Journal:  Nat Methods       Date:  2018-07-16       Impact factor: 28.547

3.  Gene expression cancer classification using modified K-Nearest Neighbors technique.

Authors:  Sarah M Ayyad; Ahmed I Saleh; Labib M Labib
Journal:  Biosystems       Date:  2019-01-03       Impact factor: 1.973

4.  Genomic classifier ColoPrint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factors.

Authors:  Scott Kopetz; Josep Tabernero; Robert Rosenberg; Zhi-Qin Jiang; Víctor Moreno; Thomas Bachleitner-Hofmann; Giovanni Lanza; Lisette Stork-Sloots; Dipen Maru; Iris Simon; Gabriel Capellà; Ramon Salazar
Journal:  Oncologist       Date:  2015-01-05

5.  Comparing normalization methods and the impact of noise.

Authors:  Thao Vu; Eli Riekeberg; Yumou Qiu; Robert Powers
Journal:  Metabolomics       Date:  2018-08-10       Impact factor: 4.290

6.  STAR: ultrafast universal RNA-seq aligner.

Authors:  Alexander Dobin; Carrie A Davis; Felix Schlesinger; Jorg Drenkow; Chris Zaleski; Sonali Jha; Philippe Batut; Mark Chaisson; Thomas R Gingeras
Journal:  Bioinformatics       Date:  2012-10-25       Impact factor: 6.937

7.  Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis.

Authors:  Tobias Herold; Stephanie Schneider; Klaus H Metzeler; Martin Neumann; Luise Hartmann; Kathryn G Roberts; Nikola P Konstandin; Philipp A Greif; Kathrin Bräundl; Bianka Ksienzyk; Natalia Huk; Irene Schneider; Evelyn Zellmeier; Vindi Jurinovic; Ulrich Mansmann; Wolfgang Hiddemann; Charles G Mullighan; Stefan K Bohlander; Karsten Spiekermann; Dieter Hoelzer; Monika Brüggemann; Claudia D Baldus; Martin Dreyling; Nicola Gökbuget
Journal:  Haematologica       Date:  2016-08-25       Impact factor: 9.941

8.  Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.

Authors:  Roland Schmitz; George W Wright; Da Wei Huang; Calvin A Johnson; James D Phelan; James Q Wang; Sandrine Roulland; Monica Kasbekar; Ryan M Young; Arthur L Shaffer; Daniel J Hodson; Wenming Xiao; Xin Yu; Yandan Yang; Hong Zhao; Weihong Xu; Xuelu Liu; Bin Zhou; Wei Du; Wing C Chan; Elaine S Jaffe; Randy D Gascoyne; Joseph M Connors; Elias Campo; Armando Lopez-Guillermo; Andreas Rosenwald; German Ott; Jan Delabie; Lisa M Rimsza; Kevin Tay Kuang Wei; Andrew D Zelenetz; John P Leonard; Nancy L Bartlett; Bao Tran; Jyoti Shetty; Yongmei Zhao; Dan R Soppet; Stefania Pittaluga; Wyndham H Wilson; Louis M Staudt
Journal:  N Engl J Med       Date:  2018-04-12       Impact factor: 91.245

9.  Parallel comparison of Illumina RNA-Seq and Affymetrix microarray platforms on transcriptomic profiles generated from 5-aza-deoxy-cytidine treated HT-29 colon cancer cells and simulated datasets.

Authors:  Xiao Xu; Yuanhao Zhang; Jennie Williams; Eric Antoniou; W Richard McCombie; Song Wu; Wei Zhu; Nicholas O Davidson; Paula Denoya; Ellen Li
Journal:  BMC Bioinformatics       Date:  2013-06-28       Impact factor: 3.169

10.  Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy.

Authors:  Chulin Sha; Sharon Barrans; Francesco Cucco; Michael A Bentley; Matthew A Care; Thomas Cummin; Hannah Kennedy; Joe S Thompson; Rahman Uddin; Lisa Worrillow; Rebecca Chalkley; Moniek van Hoppe; Sophia Ahmed; Tom Maishman; Josh Caddy; Anna Schuh; Christoph Mamot; Catherine Burton; Reuben Tooze; Andrew Davies; Ming-Qing Du; Peter W M Johnson; David R Westhead
Journal:  J Clin Oncol       Date:  2018-12-03       Impact factor: 44.544

View more
  1 in total

Review 1.  Linear and Circular Long Non-Coding RNAs in Acute Lymphoblastic Leukemia: From Pathogenesis to Classification and Treatment.

Authors:  Yasen Maimaitiyiming; Linyan Ye; Tao Yang; Wenjuan Yu; Hua Naranmandura
Journal:  Int J Mol Sci       Date:  2022-04-18       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.